Medicines authorised in Romania

Rydapt

Rydapt is a medicine containing Midostaurin, listed in the Romanian national register of medicines for human use with 1 presentation.

General information from the official register, not medical advice. Anpheros does not diagnose and does not recommend medicines. Read the package leaflet and ask your doctor or pharmacist before taking any medicine.

At a glance

Active substance
MIDOSTAURINUM
ATC code
L01EX10 Antineoplastic and immunomodulating agents
Therapeutic action
INHIBITORI DE PROTEIN-KINAZA ALTI INHIBITORI DE PROTEIN KINAZA
Prescription
Prescription required (register code PR)
Marketing authorisation holder
NOVARTIS EUROPHARM LIMITED - IRLANDA
Manufacturer
NOVARTIS PHARMA GMBH - GERMANIA
Pharmaceutical form
CAPS. MOI

Presentations and codes

CIM is the code of each pack in the Romanian register; the Anpheros app saves it when it recognises the box.

CIM codeFormStrengthPackPrescriptionAuthorisationShelf life
W64447001CAPS. MOI25mgCutie cu blist. PA-Al-PVC/Al x 112 (4x28) caps. moiPR1218/2017/013 ani

What it is used for

The official indications for Midostaurin, quoted from the European Medicines Agency and the US FDA, are on Midostaurin in Anpheros Search.

The package leaflet and the summary of product characteristics are published by ANMDMR: search for “Rydapt” in the national register.

Scan the box in Anpheros

In the Anpheros Daily app, photograph the medicine box: the app reads the name and strength, matches them against this register and adds the medicine to your list, with its code. From your list you can come back to this page.

Get the app

Source: ANMDMR — National Agency for Medicines and Medical Devices of Romania, Nomenclatorul medicamentelor de uz uman (register updated 29 October 2026). Shown as published, in Romanian where the register is in Romanian.